Daiwa Securities Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.01M | Buy |
25,700
+2,700
| +12% | +$184K | ﹤0.01% | 691 |
|
|
2026
Q1 | $1.49M | Buy |
23,000
+3,606
| +19% | +$254K | ﹤0.01% | 710 |
|
|
2025
Q4 | $1.3M | Buy |
19,394
+6,049
| +45% | +$407K | ﹤0.01% | 739 |
|
|
2025
Q3 | $979K | Buy |
13,345
+9,320
| +232% | +$619K | ﹤0.01% | 764 |
|
|
2025
Q2 | $209K | Buy |
4,025
+3,630
| +919% | +$207K | ﹤0.01% | 952 |
|
|
2025
Q1 | $25K | Sell |
395
-25
| -6% | -$1.45K | ﹤0.01% | 1063 |
|
|
2024
Q4 | $20K | Sell |
420
-49
| -10% | -$2.51K | ﹤0.01% | 1085 |
|
|
2024
Q3 | $27K | Hold |
469
| – | – | ﹤0.01% | 1092 |
|
|
2024
Q2 | $25K | Hold |
469
| – | – | ﹤0.01% | 1125 |
|
|
2024
Q1 | $19K | Sell |
469
-71
| -13% | -$2.66K | ﹤0.01% | 1139 |
|
|
2023
Q4 | $20K | Buy |
540
+66
| +14% | +$2.49K | ﹤0.01% | 1127 |
|
|
2023
Q3 | $18K | Hold |
474
| – | – | ﹤0.01% | 1100 |
|
|
2023
Q2 | $17K | Sell |
474
-70
| -13% | -$2.39K | ﹤0.01% | 1109 |
|
|
2023
Q1 | $21K | Hold |
544
| – | – | ﹤0.01% | 1074 |
|
|
2022
Q4 | $31K | Buy |
544
+30
| +6% | +$1.54K | ﹤0.01% | 1068 |
|
|
2022
Q3 | $20K | Hold |
514
| – | – | ﹤0.01% | 1097 |
|
|
2022
Q2 | $23K | Buy |
514
+103
| +25% | +$4.46K | ﹤0.01% | 1111 |
|
|
2022
Q1 | $16K | Hold |
411
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q4 | $17K | Sell |
411
-76
| -16% | -$2.84K | ﹤0.01% | 1124 |
|
|
2021
Q3 | $20K | Buy |
487
+219
| +82% | +$9.16K | ﹤0.01% | 1106 |
|
|
2021
Q2 | $12K | Hold |
268
| – | – | ﹤0.01% | 1037 |
|
|
2021
Q1 | $11K | Buy |
268
+14
| +6% | +$639 | ﹤0.01% | 1042 |
|
|
2020
Q4 | $11K | Sell |
254
-515
| -67% | -$18.5K | ﹤0.01% | 1014 |
|
|
2020
Q3 | $20K | Hold |
769
| – | – | ﹤0.01% | 993 |
|
|
2020
Q2 | $14K | Hold |
769
| – | – | ﹤0.01% | 1047 |
|
|
2020
Q1 | $14K | Sell |
769
-58
| -7% | -$1.1K | ﹤0.01% | 1035 |
|
|
2019
Q4 | $15K | Sell |
827
-95
| -10% | -$1.65K | ﹤0.01% | 1034 |
|
|
2019
Q3 | $14K | Hold |
922
| – | – | ﹤0.01% | 1014 |
|
|
2019
Q2 | $16K | Hold |
922
| – | – | ﹤0.01% | 1027 |
|
|
2019
Q1 | $15K | Buy |
922
+135
| +17% | +$2.19K | ﹤0.01% | 1005 |
|
|
2018
Q4 | $12K | Hold |
787
| – | – | ﹤0.01% | 988 |
|
|
2018
Q3 | $14K | Hold |
787
| – | – | ﹤0.01% | 1012 |
|
|
2018
Q2 | $13K | Hold |
787
| – | – | ﹤0.01% | 1035 |
|
|
2018
Q1 | $15K | Buy |
+787
| New | +$15.2K | ﹤0.01% | 1001 |
|
Other funds holding HALO
Daiwa Securities Group's HALO Position: Q2 2026 in Review
Daiwa Securities Group increased its Halozyme (HALO) stake by 12% in Q2 2026, buying an estimated $184K and bringing the position to 25,700 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #691.
Daiwa Securities Group first reported a position in HALO in Q1 2018 and has held it in 34 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Daiwa Securities Group held 25,700 shares of Halozyme worth $2.01M as of Q2 2026.
- Daiwa Securities Group bought 2,700 Halozyme shares in Q2 2026, an estimated $184K.
- Halozyme made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #691 holding.
- Daiwa Securities Group first reported a position in Halozyme in Q1 2018 and has held it in 34 quarters since.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.